All this would support the existing evidence of oral/oropharyngeal cancer etiologically associated with HPV having an increased survival and a better prognostic, as both an over-expression of P16 and very low P53 mutation rates would happen, and all this might be linked to infected cells being more sensitive to current radiotherapy and chemotherapy (28,29). This evidence concerns the gene TP53 and oropharynx cancer.